Relationship Between Porphyromonas Gingivalis and Obesity in Patients With Periodontitis
PAROBIOTA
Non-interventional Study Exploring the Relationship Between Porphyromonas Gingivalis and Obesity in Patients With Periodontitis
1 other identifier
observational
311
1 country
1
Brief Summary
Obesity is recognized as a major public health problem. Recent research suggests the involvement of the gut microbiota in the development of obesity. Indeed, obese people are characterized by a dysbiotic intestinal microbiota. Periodontitis are chronic inflammatory oral pathologies linked to an imbalance between the bacterial etiological factor, oral dysbiosis, and the host's immune defenses.They lead to the destruction of the supporting tissues of the tooth and an apical migration of the periodontal attachment system, thus leading to the formation of the pathognomonic entity of the disease, the periodontal pocket.the presence of bacteria of oral origin such as Porphyromonas gingivalis (Pg) has been demonstrated in the adipose tissue of obese patients inducing a chronic low-grade inflammatory response by macrophages which leads to the proliferation of adipocyte precursors predisposing to obesity. The main objective is to assess the average amount of Porphyromonas gingivalis (Pg) in the saliva of obese people (BMI ≥ 30) with periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2022
CompletedStudy Start
First participant enrolled
December 5, 2022
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedJuly 12, 2023
July 1, 2023
1.3 years
December 5, 2022
July 5, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Analysis by bacterial culture and taxonomic analysis (MiSEQ) of the microbiological composition of saliva
Assess the microbiological composition of saliva and periodontal plaque in obese (BMI≥30) and non-obese (BMI\<30) patients with periodontitis.
8 weeks
Analysis by bacterial culture and taxonomic analysis (MiSEQ) of the microbiological composition periodontal plaque
Assess the microbiological composition of periodontal plaque in obese (BMI≥30) and non-obese (BMI\<30) patients with periodontitis.
8 weeks
Study Arms (2)
obese patients
Patients with a body mass index superior or equal at 30 and with a periodontitis
non-obese (BMI<30) patients
Patients with a body mass index inferior at 30 with a periodontitis
Interventions
Saliva samples, which are part of the usual treatment, will be carried out before and after the non-surgical periodontal treatment
Eligibility Criteria
any patient coming for consultation in the periodontology department
You may qualify if:
- over 18 years old
- having periodontitis
- able to receive information on the course of the study and to understand the information form to participate in the study.
- having given their non-objection to participate in the study
You may not qualify if:
- During pregnancy or breastfeeding
- At risk of infection (existence of one or more known chronic infectious diseases)
- Suffering from a general pathology contraindicating the performance of diagnostic procedures such as periodontal probing (patients at high risk of infective endocarditis according to the French National Agency for the Safety of Medicines and Products of Health ANSM)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UHToulouse
Toulouse, 31059, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara LAURENCIN, MD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2022
First Posted
July 12, 2023
Study Start
December 5, 2022
Primary Completion
March 27, 2024
Study Completion
December 30, 2024
Last Updated
July 12, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share